2009 Article Archive CD from the International Journal of Pharmaceutical Compounding

Sign On

Volume 13, 2009 CD
Six back issues from 2009 on one convenient CD.

Permanent storage and easy retrieval of IJPC articles and formulations.

Print journal articles in color from the PDF file for your marketing needs.
Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $95 per CD

This CD contains the following articles listed by volume, issue and page number:


Issues Included
Volume/Issue	Date	Title
Vol. 13 No. 1	January/February 2009	Compounding for Pediatrics
Vol. 13 No. 2	March/April 2009	Sterile Compounding
Vol. 13 No. 3	May/June 2009	Pain Management
Vol. 13 No. 4	July/August 2009	Homone Replacement Therapy
Vol. 13 No. 5	September/October 2009	Veterinary Compounding
Vol. 13 No. 6	November/December 2009	Geriatric Compounding

Volume 13, 2009 CD ARTICLES

Title (Click for Details)	Vol/Issue	Page

Volume 13, 2009 CD ARTICLES
PreScription: A New Start: What Will 2009 Bring?	Vol. 13 No. 1	4
Compounding for Pediatric Patients: Case Reports and Formulations	Vol. 13 No. 1	6
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports	Vol. 13 No. 1	14
Compounding for Manufacturer Backorders and Discontinuations: "Oh, No! Not Again!"	Vol. 13 No. 1	20
Compounding with Sucralfate for the Treatment of External Wounds	Vol. 13 No. 1	25
Identifying the Criteria of a Valid Stability Study	Vol. 13 No. 1	32
Summertime in an American Apothecary Garden	Vol. 13 No. 1	38
Compounding for Cancer in Companion Animals	Vol. 13 No. 1	42
Technology for the Compounding Pharmacy: Digital Pens--Tools or Toys?	Vol. 13 No. 1	50
Quality Control Analytical Methods: Testing of Electrolytes Solutions	Vol. 13 No. 1	53
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs	Vol. 13 No. 1	56
Calculations	Vol. 13 No. 1	63
Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets	Vol. 13 No. 1	64
Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder	Vol. 13 No. 1	65
Dextromethorphan Hydrobromide 10% and Guaifenesin 10% Rapidly Penetrating Gel	Vol. 13 No. 1	66
Dextromethorphan Hydrobromide 30-mg Troches	Vol. 13 No. 1	67
Diaper Rash Cream with Miconazole	Vol. 13 No. 1	68
Diphenhydramine Hydrochloride 25-mg Gelatin Troches	Vol. 13 No. 1	69
Electrolyte Lollipop (Adult)	Vol. 13 No. 1	70
Hydrogen Peroxide 1.5% and Sodium Fluoride 0.5-mg/mL Oral Rinse	Vol. 13 No. 1	71
Peruvian Balsam, Zinc Stearate, Boric Acid, and Talcum Powder	Vol. 13 No. 1	72
Tetracaine 0.025% Popsicles	Vol. 13 No. 1	73
Testing of Estradiol in a Compounded Cream and a Stock Solution	Vol. 13 No. 1	74
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration	Vol. 13 No. 1	78
The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials	Vol. 13 No. 1	81
PostScription: The Compounding Pharmacy in Brazil: A Pharmacist's Perspective	Vol. 13 No. 1	87
PreScription: Electronic Prescribing	Vol. 13 No. 2	92
Compliance by Hospitals and Healthcare Facilities with the Revised United States Pharmacopeia Chapter <797>	Vol. 13 No. 2	94
Tips for Cleanroom Construction and Renovation	Vol. 13 No. 2	100
Contract Sterilization and Validation Companies Offer New Options for Sterile Compounded Preparations	Vol. 13 No. 2	106
Treating Methicillin-Resistant Staphylococcus Aureus Infections with Compounded Vancomycin Preparations	Vol. 13 No. 2	120
Compendial Activities Relating to Cold Chain Management Issues: Drug Products and Compounded Preparations	Vol. 13 No. 2	128
Incorporating Web Communication to Maximize Staff Productivity in a Compounding Pharmacy	Vol. 13 No. 2	138
Blogging for Business	Vol. 13 No. 2	141
Quality-Control Analytical Methods: Compounding Slow-Release Pharmaceuticals	Vol. 13 No. 2	144
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 12: Sterilization Methods	Vol. 13 No. 2	146
Calculations	Vol. 13 No. 2	151
Acidified Sodium Hypochlorite for Antisepsis and Disinfection	Vol. 13 No. 2	152
Aprepitant 20-mg/mL Oral Liquid	Vol. 13 No. 2	153
Chloroquine Phosphate 64.5-mg/mL Injection	Vol. 13 No. 2	154
Doxorubicin Hydrochloride 1-mg/mL in Sodium Chloride Solution Intravesical Instillation	Vol. 13 No. 2	155
Ionic Hydration Solution for Anti-Cancer Therapy	Vol. 13 No. 2	156
Metronidazole 2.1-mg/mL in 5.25% Dextrose Injection	Vol. 13 No. 2	157
Nicotine Rectal Enema	Vol. 13 No. 2	158
Thiothixene Hydrochloride 2-mg/mL Injection	Vol. 13 No. 2	159
Tolterodine 2-mg/5-mL Oral Suspension	Vol. 13 No. 2	160
Vasopressin Tannate 5 Pressor Units Per mL in Oil Injection	Vol. 13 No. 2	161
Drug Compatibility with a New Generation of VISIV Polyolefin Infusion Solution Containers	Vol. 13 No. 2	162
Stability of Low-Concentration Ceftazidime in 0.9% Sodium Chloride Injection and Balanced Salt Solutions in Plastic Syringes Under Various Storage Conditions	Vol. 13 No. 2	166
Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule	Vol. 13 No. 2	170
PostScription: Compounding in Argentina	Vol. 13 No. 2	175
PreScription: A Good Name: Pharmacy	Vol. 13 No. 3	180
Update on Managing Neuropathic Pain	Vol. 13 No. 3	182
Elegant Compounded Solutions for the Treatment of Thrombosed External Hemorrhoids	Vol. 13 No. 3	192
Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report	Vol. 13 No. 3	196
Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers	Vol. 13 No. 3	214
Safe Use of Topical Local Anesthetic Medications for Pain Management	Vol. 13 No. 3	218
Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report	Vol. 13 No. 3	220
Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education	Vol. 13 No. 3	224
Quality-Control Analytical Methods: Pharmaceutical and Analytical Considerations of the Significance of pH	Vol. 13 No. 3	230
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control	Vol. 13 No. 3	234
Calculations	Vol. 13 No. 3	239
Analgesic Compound Lotion, Clear	Vol. 13 No. 3	240
Hydromorphone Hydrochloride 10-mg/mL Oral Drops	Vol. 13 No. 3	241
Lidocaine 2% Popsicle	Vol. 13 No. 3	242
Morphine Sulfate 10-mg/mL Oral Solution	Vol. 13 No. 3	243
Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel	Vol. 13 No. 3	244
Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel	Vol. 13 No. 3	245
Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules	Vol. 13 No. 3	246
Oxycodone Hydrochloride 20-mg Suppository	Vol. 13 No. 3	247
Promethazine 20-mg and Acetaminophen 325-mg Suppositories	Vol. 13 No. 3	248
Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules	Vol. 13 No. 3	249
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding	Vol. 13 No. 3	250
Stability of Pergolide Mesylate Oral Liquid at Room Temperature	Vol. 13 No. 3	254
Formulation Optimization Study for an Immediate-Release Tablet	Vol. 13 No. 3	259
PostScription: Compounding in Israel	Vol. 13 No. 3	262
PreScription: Trust	Vol. 13 No. 4	268
The Physiologic Role and Use of Estriol	Vol. 13 No. 4	270
Hormone Treatment Options for Males: What to Do for Men with Low Testosterone	Vol. 13 No. 4	276
Saliva Tests, Part 1: Clinical Use, Elements of Testing, and Guidelines for Posttreatment Interpretation	Vol. 13 No. 4	280
Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients	Vol. 13 No. 4	290
Compounding Naltrexone for the Treatment of Autism	Vol. 13 No. 4	296
Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting	Vol. 13 No. 4	300
Optimizing Your Website: Search Engine Optimization, Pay Per Click, Email Marketing	Vol. 13 No. 4	311
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding	Vol. 13 No. 4	314
Quality-Control Analytical Methods: Quality Control, Quality Assurance, and Quality Improvement--What is the Difference and Why Should Compounding Pharmacies Care?	Vol. 13 No. 4	318
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued)	Vol. 13 No. 4	322
Calculations	Vol. 13 No. 4	330
Alcohol-based Carbomer Gel	Vol. 13 No. 4	332
Benzoyl Peroxide 10% Gel	Vol. 13 No. 4	333
Clindamycin 100-mg Vaginal Suppositories	Vol. 13 No. 4	334
Dexamethasone and Furosemide Injection	Vol. 13 No. 4	335
Instant Voice	Vol. 13 No. 4	336
Moxifloxacin 20-mg/mL Oral Liquid	Vol. 13 No. 4	337
Mupirocin 1% (20-mg) Vaginal Suppository	Vol. 13 No. 4	338
Riley Butt Cream	Vol. 13 No. 4	339
Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil	Vol. 13 No. 4	340
Trolamine Oleate Otic Solution	Vol. 13 No. 4	341
Quality of Progesterone Suppositories Prepared by FIRST-Progesterone VGS 50 Kit or Traditional Compounding Method: In Vitro Comparison	Vol. 13 No. 4	342
Women's Perspective on Progesterone: A Qualitative Study Conducted in Australia	Vol. 13 No. 4	345
PostScription: Compounding Pharmacy in Puerto Rico	Vol. 13 No. 4	350
PreScription: Veterinary Pharmacy	Vol. 13 No. 5	356
Transdermal Dosing Considerations for Veterinarians	Vol. 13 No. 5	358
Little Thief: The Domestic Ferret	Vol. 13 No. 5	362
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret	Vol. 13 No. 5	367
A Review of Stomatitis and Treatment in Cats	Vol. 13 No. 5	372
Azithromycin in the Treatment of Pneumonic Foals	Vol. 13 No. 5	382
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses	Vol. 13 No. 5	386
Recommended Tips for Treating Veterinary Patients	Vol. 13 No. 5	390
Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing	Vol. 13 No. 5	392
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications	Vol. 13 No. 5	400
An Abridged History of Aspirin	Vol. 13 No. 5	404
Marketing Veterinarians	Vol. 13 No. 5	410
Quality-Control Analytical Methods: Designing a Quality-Control Potency Testing Program for a Compounding Pharmacy	Vol. 13 No. 5	412
Calculations	Vol. 13 No. 5	419
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chater <797> Pharmaceutical Compounding--Sterile Preparations, Part 15: Personnel Training, Cleansing, and Garbing	Vol. 13 No. 5	420
Aceclofenac 1.5% Pluronic Lecithin Organogel	Vol. 13 No. 5	428
Amlodipine Besylate 1 mg/mL Veterinary Suspension	Vol. 13 No. 5	429
Cooling Ointment	Vol. 13 No. 5	430
Emanuel Butt Paste	Vol. 13 No. 5	431
Ferric Pyrophosphate 50-mg/mL Solution for Iontophoresis	Vol. 13 No. 5	432
Lidocaine 10% Oral Pluronic Lecithin Organogel	Vol. 13 No. 5	433
Mechlorethamine Hydrochloride 0.02% Topical	Vol. 13 No. 5	434
Myristyl Nicotinate 5% Topical Gel	Vol. 13 No. 5	435
Nitroglycerin 4-mg Suppository	Vol. 13 No. 5	436
Zonisamide 10-mg/mL Oral Suspension	Vol. 13 No. 5	437
Chemical Stability of Scopolamine Hydrobromide Nasal Solution	Vol. 13 No. 5	438
Compounding Solutions for Exotic and Nondomesticated Fauna in Australia: An Investigative Study	Vol. 13 No. 5	440
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms	Vol. 13 No. 5	445
PostScription: Setting up a National System of Compounding Pharmacies: An Introduction	Vol. 13 No. 5	447
PreScription: Geriatric Compounding: An Opportunity for Pharmacists	Vol. 13 No. 6	492
Low Testosterone in Older Men: A Discussion and Review of Literature on Health Consequences of Hypogonadism in the Aging Male	Vol. 13 No. 6	494
Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms	Vol. 13 No. 6	498
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis	Vol. 13 No. 6	506
Urinary Deoxypyridinoline Level Reveals Bone Resorption, Predicts Fracture Risk, and Enhances the Results of Dual Energy X-Ray Absorptiometry	Vol. 13 No. 6	516
An Overview of United States Pharmacopeia Chapter <795> and American Society of Health-System Pharmacists Guidelines for Nonsterile Compounding	Vol. 13 No. 6	525
Setting Up a National System of Compounding Pharmacies: Preventing Error, Assuring Quality, Building Trust	Vol. 13 No. 6	532
Marketing the Geriatric Patient	Vol. 13 No. 6	538
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops	Vol. 13 No. 6	540
Calculations	Vol. 13 No. 6	545
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 16: Suggested Standard Operating Procedures	Vol. 13 No. 6	546
Cidofovir 0.2-mg/mL Intravitreous Injection	Vol. 13 No. 6	554
Fluconazole 2% Topical Microemulsion	Vol. 13 No. 6	555
Gentian Violet Vaginal Suppositories	Vol. 13 No. 6	556
Ichthammol 10% Otic Solution	Vol. 13 No. 6	557
Lubow's Solution	Vol. 13 No. 6	558
Miconazole 1% Ophthalmic Solution, Veterinary	Vol. 13 No. 6	559
Topiramate 6-mg/mL Oral Suspension	Vol. 13 No. 6	560
Twevan Cream	Vol. 13 No. 6	561
Voriconazole 2% Ophthalmic Solution	Vol. 13 No. 6	562
Wound Gel	Vol. 13 No. 6	563
Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes	Vol. 13 No. 6	564
The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel	Vol. 13 No. 6	569
Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions	Vol. 13 No. 6	572
PostScription: Compounding Seminar: International Pharmaceutical Federation Congress--Istanbul	Vol. 13 No. 6	574